172 related articles for article (PubMed ID: 36253777)
1. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
He JY; Li ZM; Chen YT; Zhao BH; Yu C
Transl Cancer Res; 2024 Apr; 13(4):1721-1736. PubMed ID: 38737688
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation.
Huang Y; Li L; Kang Z; Luo H; Lin X; Zhao S; Zhang Q; Li Q; Liu H; Li M
Front Biosci (Landmark Ed); 2024 Mar; 29(3):98. PubMed ID: 38538261
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
Wang H; Wang W; Wang Z; Li X
Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of a novel lysosome-related gene signature for predicting prognosis and immune landscape in hepatocellular carcinoma.
Li H; Li J; Qu X; Dai H; Liu J; Ma M; Wang J; Dong W; Wang W
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17543-17557. PubMed ID: 37903936
[TBL] [Abstract][Full Text] [Related]
7. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma.
Xiang Z; Mranda GM; Zhou X; Xue Y; Wang Y; Wei T; Liu J; Ding Y
Medicine (Baltimore); 2022 Sep; 101(36):e30219. PubMed ID: 36086716
[TBL] [Abstract][Full Text] [Related]
9. A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma.
Zhao S; Wang T; Huang F; Zhao Q; Gong D; Liu J; Yi C; Liang S; Bian E; Tian D; Jing J
Biochem Genet; 2024 Apr; 62(2):831-852. PubMed ID: 37460861
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
Qin R; Cao L; Ye C; Wang J; Sun Z
BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
Ji D; Zhong R; Fan S
Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
[TBL] [Abstract][Full Text] [Related]
12. Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
Zhu Z; Lu J
Medicine (Baltimore); 2024 May; 103(19):e38116. PubMed ID: 38728474
[TBL] [Abstract][Full Text] [Related]
13. NET-related gene signature for predicting AML prognosis.
Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z
Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity.
Xu J; Huang X; Gou S; Luo H; Zeng S; Zhang Q; Wu Q; Chi H; Yang G
J Cancer; 2024; 15(9):2788-2804. PubMed ID: 38577592
[No Abstract] [Full Text] [Related]
15. Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer.
Qin Y; Sheng Y; Ren M; Hou Z; Xiao L; Chen R
Sci Rep; 2024 May; 14(1):11133. PubMed ID: 38750159
[TBL] [Abstract][Full Text] [Related]
16. A novel mitochondria-related core gene signature to predict the prognosis and evaluate tumour microenvironment in CESC single-cell validation.
Ying L; Kong L; Qiu X; Cheng A; Wang Q; Xiu L; Shi J; Tao Y; Chai Z
J Cell Mol Med; 2024 Apr; 28(8):e18265. PubMed ID: 38534098
[TBL] [Abstract][Full Text] [Related]
17. Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
Zhao X; Fan X; Lin X; Guo B; Yu Y
Medicine (Baltimore); 2024 Apr; 103(15):e37717. PubMed ID: 38608077
[TBL] [Abstract][Full Text] [Related]
18. A novel gene signature related to fatty acid metabolism predicts prognosis, immune landscape, and drug sensitivity in early-stage lung squamous cell carcinoma.
Xu J; Yu M; Fan W; Feng J
Transl Cancer Res; 2024 Feb; 13(2):525-541. PubMed ID: 38482436
[TBL] [Abstract][Full Text] [Related]
19. The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
Zhang X; Yang J; Feng Q; Gu L; Qin G; Cheng C; Hou S; Shi Z
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38597597
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis-related lncRNAs index: A predictor for CESC prognosis, immunotherapy efficacy, and chemosensitivity.
Huang X; Yi G; Xu J; Gou S; Chen H; Chen X; Quan X; Xie L; Teichmann AT; Yang G; Chi H; Wang Q
J Cancer; 2024; 15(10):3095-3113. PubMed ID: 38706901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
